Erythromycin Enhances CD4^+Foxp3^+ Regulatory T-Cell Responses in a Rat Model of Smoke-Induced Lung Inflammation
Heavy smoking can induce airway inflammation and emphysema. Macrolides can modulate inflammation and effector T-cell response in the lungs. However, there is no information on whether erythromycin can modulate regulatory T-cell (Treg) response. This study is aimed at examining the impact of erythrom...
Saved in:
Published in | Mediators of Inflammation Vol. 2012; no. 2012; pp. 725 - 733 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Cairo, Egypt
Hindawi Limiteds
01.01.2012
Hindawi Publishing Corporation Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Heavy smoking can induce airway inflammation and emphysema. Macrolides can modulate inflammation and effector T-cell response in the lungs. However, there is no information on whether erythromycin can modulate regulatory T-cell (Treg) response. This study is aimed at examining the impact of erythromycin on Treg response in the lungs in a rat model of smoking-induced emphysema. Male Wistar rats were exposed to normal air or cigarette smoking daily for 12 weeks and treated by gavage with 100 mg/kg of erythromycin or saline daily beginning at the forth week for nine weeks. The lung inflammation and the numbers of inflammatory infiltrates in bronchoalveolar lavage fluid (BALF) were characterized. The frequency, the number of Tregs, and the levels of Foxp3 expression in the lungs and IL-8, IL-35, and TNF-α in BALF were determined by flow cytometry, RT-PCR and ELISA, respectively. Treatment with erythromycin reduced smoking-induced inflammatory infiltrates, the levels of IL-8 and TNF-α in the BALF and lung damages but increased the numbers of CD4+Foxp3+ Tregs and the levels of Foxp3 transcription in the lungs, accompanied by increased levels of IL-35 in the BALF of rats. Our novel data indicated that erythromycin enhanced Treg responses, associated with the inhibition of smoking-induced inflammation in the lungs of rats. |
---|---|
AbstractList | Heavy smoking can induce airway inflammation and emphysema. Macrolides can modulate inflammation and effector T-cell response in the lungs. However, there is no information on whether erythromycin can modulate regulatory T-cell (Treg) response. This study is aimed at examining the impact of erythromycin on Treg response in the lungs in a rat model of smoking-induced emphysema. Male Wistar rats were exposed to normal air or cigarette smoking daily for 12 weeks and treated by gavage with 100 mg/kg of erythromycin or saline daily beginning at the forth week for nine weeks. The lung inflammation and the numbers of inflammatory infiltrates in bronchoalveolar lavage fluid (BALF) were characterized. The frequency, the number of Tregs, and the levels of Foxp3 expression in the lungs and IL-8, IL-35, and TNF-α in BALF were determined by flow cytometry, RT-PCR and ELISA, respectively. Treatment with erythromycin reduced smoking-induced inflammatory infiltrates, the levels of IL-8 and TNF-α in the BALF and lung damages but increased the numbers of CD4+Foxp3+ Tregs and the levels of Foxp3 transcription in the lungs, accompanied by increased levels of IL-35 in the BALF of rats. Our novel data indicated that erythromycin enhanced Treg responses, associated with the inhibition of smoking-induced inflammation in the lungs of rats. Heavy smoking can induce airway inflammation and emphysema. Macrolides can modulate inflammation and effector T-cell response in the lungs. However, there is no information on whether erythromycin can modulate regulatory T-cell (Treg) response. This study is aimed at examining the impact of erythromycin on Treg response in the lungs in a rat model of smoking-induced emphysema. Male Wistar rats were exposed to normal air or cigarette smoking daily for 12 weeks and treated by gavage with 100 mg/kg of erythromycin or saline daily beginning at the forth week for nine weeks. The lung inflammation and the numbers of inflammatory infiltrates in bronchoalveolar lavage fluid (BALF) were characterized. The frequency, the number of Tregs, and the levels of Foxp3 expression in the lungs and IL-8, IL-35, and TNF-α in BALF were determined by flow cytometry, RT-PCR and ELISA, respectively. Treatment with erythromycin reduced smoking-induced inflammatory infiltrates, the levels of IL-8 and TNF-α in the BALF and lung damages but increased the numbers of CD4 + Foxp3 + Tregs and the levels of Foxp3 transcription in the lungs, accompanied by increased levels of IL-35 in the BALF of rats. Our novel data indicated that erythromycin enhanced Treg responses, associated with the inhibition of smoking-induced inflammation in the lungs of rats. Heavy smoking can induce airway inflammation and emphysema. Macrolides can modulate inflammation and effector T-cell response in the lungs. However, there is no information on whether erythromycin can modulate regulatory T-cell (Treg) response. This study is aimed at examining the impact of erythromycin on Treg response in the lungs in a rat model of smoking-induced emphysema. Male Wistar rats were exposed to normal air or cigarette smoking daily for 12 weeks and treated by gavage with 100 mg/kg of erythromycin or saline daily beginning at the forth week for nine weeks. The lung inflammation and the numbers of inflammatory infiltrates in bronchoalveolar lavage fluid (BALF) were characterized. The frequency, the number of Tregs, and the levels of Foxp3 expression in the lungs and IL-8, IL-35, and TNF- α in BALF were determined by flow cytometry, RT-PCR and ELISA, respectively. Treatment with erythromycin reduced smoking-induced inflammatory infiltrates, the levels of IL-8 and TNF- α in the BALF and lung damages but increased the numbers of CD4 + Foxp3 + Tregs and the levels of Foxp3 transcription in the lungs, accompanied by increased levels of IL-35 in the BALF of rats. Our novel data indicated that erythromycin enhanced Treg responses, associated with the inhibition of smoking-induced inflammation in the lungs of rats. Heavy smoking can induce airway inflammation and emphysema. Macrolides can modulate inflammation and effector T-cell response in the lungs. However, there is no information on whether erythromycin can modulate regulatory T-cell (Treg) response. This study is aimed at examining the impact of erythromycin on Treg response in the lungs in a rat model of smoking-induced emphysema. Male Wistar rats were exposed to normal air or cigarette smoking daily for 12 weeks and treated by gavage with 100 mg/kg of erythromycin or saline daily beginning at the forth week for nine weeks. The lung inflammation and the numbers of inflammatory infiltrates in bronchoalveolar lavage fluid (BALF) were characterized. The frequency, the number of Tregs, and the levels of Foxp3 expression in the lungs and IL-8, IL-35, and TNF-α in BALF were determined by flow cytometry, RT-PCR and ELISA, respectively. Treatment with erythromycin reduced smoking-induced inflammatory infiltrates, the levels of IL-8 and TNF-α in the BALF and lung damages but increased the numbers of CD4+Foxp3+ Tregs and the levels of Foxp3 transcription in the lungs, accompanied by increased levels of IL-35 in the BALF of rats. Our novel data indicated that erythromycin enhanced Treg responses, associated with the inhibition of smoking-induced inflammation in the lungs of rats.Heavy smoking can induce airway inflammation and emphysema. Macrolides can modulate inflammation and effector T-cell response in the lungs. However, there is no information on whether erythromycin can modulate regulatory T-cell (Treg) response. This study is aimed at examining the impact of erythromycin on Treg response in the lungs in a rat model of smoking-induced emphysema. Male Wistar rats were exposed to normal air or cigarette smoking daily for 12 weeks and treated by gavage with 100 mg/kg of erythromycin or saline daily beginning at the forth week for nine weeks. The lung inflammation and the numbers of inflammatory infiltrates in bronchoalveolar lavage fluid (BALF) were characterized. The frequency, the number of Tregs, and the levels of Foxp3 expression in the lungs and IL-8, IL-35, and TNF-α in BALF were determined by flow cytometry, RT-PCR and ELISA, respectively. Treatment with erythromycin reduced smoking-induced inflammatory infiltrates, the levels of IL-8 and TNF-α in the BALF and lung damages but increased the numbers of CD4+Foxp3+ Tregs and the levels of Foxp3 transcription in the lungs, accompanied by increased levels of IL-35 in the BALF of rats. Our novel data indicated that erythromycin enhanced Treg responses, associated with the inhibition of smoking-induced inflammation in the lungs of rats. |
Author | Huang, Qiu-Ping Qiu, Shi-Lin He, Zhi-Yi Li, Mei-Hua Bai, Jing Deng, Jing-Min Liu, Guang-Nan Zhong, Xiao-Ning Zhang, Jian-Quan |
AuthorAffiliation | Department of Respiratory Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning 530000, China |
AuthorAffiliation_xml | – name: Department of Respiratory Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning 530000, China |
Author_xml | – sequence: 1 fullname: Deng, Jing-Min – sequence: 2 fullname: Li, Mei-Hua – sequence: 3 fullname: Zhang, Jian-Quan – sequence: 4 fullname: He, Zhi-Yi – sequence: 5 fullname: Huang, Qiu-Ping – sequence: 6 fullname: Zhong, Xiao-Ning – sequence: 7 fullname: Qiu, Shi-Lin – sequence: 8 fullname: Bai, Jing – sequence: 9 fullname: Liu, Guang-Nan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22701274$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkt9v0zAQgCM0xLrBE8-gPCKqMP-KnbxMQqWDSkWgMV5nXRy7dUns4iRA_3vcZpsoQuLpZN9330l3d5acOO90kjzH6A3GeX5BECYXDCNCyaNkghnnGS44PkkmqOQkK2mOT5OzrtsghHLGiifJKSEiFgk2SbbzsOvXwbc7ZV06d2twSnfp7B27nV75X1t6O02v9WpooPdhl95kM9008afbetdFMBZBeg19-tHXukm9Sb-0_pvOFq4elK7T5eBW6cKZBtoWeuvd0-SxgabTz-7iefL1an4z-5AtP71fzN4uM8gp7zNhQFfU5IrrQrOSK6WIqnEBAoAZTglh3CCBWCHyoqoA0yrXBedIM0VVaeh5shi9tYeN3AbbQthJD1YePnxYSQi9VY2WTICJ1UIwYAzAAK5MoQWPekR1XUfX5ejaDlWra6VdH6A5kh5nnF3Llf8hKRWY5nkUvLoTBP990F0vW9upOElw2g-djMtDBSlG9OWfvR6a3K8sAngEVPBdF7SRyvaH0cbWtokuuT8LuT8LOZ5FrJn-VXOv_Tf9eqTX1tXw0_4HfjHCOiLawANclkWJ9vnlmAcbbG_lxg_BxcXLz9HCUU72Qz4YozMGgSjCCGF2_BAkl4JS-huraeJx |
CitedBy_id | crossref_primary_10_1152_ajplung_00180_2022 crossref_primary_10_1080_15412555_2016_1192112 crossref_primary_10_1016_j_molimm_2021_01_009 crossref_primary_10_1155_2020_1387952 crossref_primary_10_5582_ddt_2018_01008 crossref_primary_10_1097_CM9_0000000000000248 crossref_primary_10_1007_s10266_023_00843_8 crossref_primary_10_3109_02770903_2015_1038390 crossref_primary_10_1016_j_intimp_2022_108938 crossref_primary_10_1152_ajplung_00292_2014 crossref_primary_10_1111_1751_2980_12218 crossref_primary_10_1177_1753465816682677 crossref_primary_10_3389_fimmu_2018_01545 crossref_primary_10_1002_mrm_26566 crossref_primary_10_1089_jir_2012_0086 crossref_primary_10_1186_s13054_024_05006_x crossref_primary_10_1016_j_jneuroim_2019_05_005 crossref_primary_10_3389_fphar_2014_00233 crossref_primary_10_1016_j_cca_2016_09_005 crossref_primary_10_1111_imm_13820 crossref_primary_10_1016_j_rmed_2016_06_021 crossref_primary_10_1016_j_bbrc_2015_07_133 crossref_primary_10_1016_j_healun_2015_10_041 crossref_primary_10_1038_s41419_019_1909_2 |
Cites_doi | 10.1136/thx.2006.071068 10.1164/rccm.200806-905OC 10.1111/j.1365-2249.2005.02754.x 10.1378/chest.125.2_suppl.70S 10.1146/annurev.immunol.18.1.423 10.1038/nm1583 10.2165/00003495-200767070-00002 10.1007/BF03256601 10.1183/09031936.00000209 10.1179/joc.2008.20.5.604 10.1164/ajrccm.165.8.2103094 10.1164/rccm.200703-456SO 10.1056/NEJMra055446 10.1371/journal.pmed.0010008 10.1111/j.1365-2567.2005.02317.x 10.1136/thorax.58.10.832 10.1164/rccm.200707-1134OC 10.1038/ni1180 10.1164/rccm.200801-145OC 10.1038/nature06306 10.1038/nm1343 10.1159/000195915 10.1080/15287398509530760 10.1038/cmi.2009.11 10.1016/j.ijporl.2006.10.016 10.1164/ajrccm.163.5.2101039 10.1002/jcb.22430 10.1152/ajplung.00093.2005 10.1136/thx.2006.072348 10.1016/j.jdermsci.2009.01.007 10.1111/j.1440-1843.2006.00845.x 10.1164/rccm.2107139 10.1016/j.coi.2005.09.002 10.4049/jimmunol.175.12.8069 |
ContentType | Journal Article |
Copyright | Copyright © 2012 Jing Bai et al. Copyright © 2012 Jing Bai et al. 2012 |
Copyright_xml | – notice: Copyright © 2012 Jing Bai et al. – notice: Copyright © 2012 Jing Bai et al. 2012 |
DBID | 188 ADJCN AHFXO RHU RHW RHX AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
DOI | 10.1155/2012/410232 |
DatabaseName | Chinese Electronic Periodical Services (CEPS) الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete Hindawi Publishing Complete Hindawi Publishing Subscription Journals Hindawi Publishing Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: RHX name: Hindawi Publishing Open Access url: http://www.hindawi.com/journals/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1466-1861 |
Editor | Asano, Kazuhito |
Editor_xml | – sequence: 1 givenname: Kazuhito surname: Asano fullname: Asano, Kazuhito |
EndPage | 733 |
ExternalDocumentID | oai_doaj_org_article_47afb5e774a44aafa1bf8e7607003edd PMC3371355 22701274 10_1155_2012_410232 998902 P20160527003_201212_201703010014_201703010014_725_733 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 188 24P 29M 2UF 2WC 36B 4.4 53G 5GY 5VS AAFWJ AAJEY ABDBF ACGFO ACIHN ADBBV ADRAZ AEAQA AENEX AFPKN AHMBA AINHJ ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS B0M BAWUL BCNDV CEFSP CNMHZ CS3 DIK DU5 E3Z EAD EAP EAS EBC EBD EBS EBX EJD EMB EMK EMOBN EPL ESX F5P GROUPED_DOAJ GX1 HYE IAO IGS IHR IL9 INH INR ITC KQ8 M48 M~E O5R O5S OK1 P2P PGMZT RHU RHX RNS RPM SV3 TR2 TUS UZ5 WOQ WOW ~8M 3V. 7X7 88E 8FE 8FH 8FI 8FJ 8G5 ABUWG ADJCN AFKRA AHFXO AZQEC BBNVY BENPR BHPHI BPHCQ BVXVI CAG CCPQU COF DWQXO FYUFA GNUQQ GUQSH H13 HCIFZ HMCUK IPNFZ LK8 M1P M2O M7P OVD PIMPY PQQKQ PROAC PSQYO RIG TEORI UKHRP RHW 0R~ AAYXX ACCMX ACUHS CITATION OVT PHGZM PHGZT AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB 7X8 5PM |
ID | FETCH-LOGICAL-a536t-7faeb3f5c6e8e496ccc2cd18a7aa4f632246f07048758bba13b5e8660e4c3c9f3 |
IEDL.DBID | M48 |
ISSN | 0962-9351 1466-1861 |
IngestDate | Wed Aug 27 01:27:46 EDT 2025 Thu Aug 21 18:06:31 EDT 2025 Fri Jul 11 05:25:50 EDT 2025 Mon Jul 21 05:50:12 EDT 2025 Tue Jul 01 03:54:30 EDT 2025 Thu Apr 24 22:53:41 EDT 2025 Sun Jun 02 18:48:58 EDT 2024 Tue Nov 26 17:08:50 EST 2024 Tue Oct 01 22:52:02 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2012 |
Language | English |
License | This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/3.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-a536t-7faeb3f5c6e8e496ccc2cd18a7aa4f632246f07048758bba13b5e8660e4c3c9f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Academic Editor: Kazuhito Asano |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1155/2012/410232 |
PMID | 22701274 |
PQID | 1020828355 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_47afb5e774a44aafa1bf8e7607003edd pubmedcentral_primary_oai_pubmedcentral_nih_gov_3371355 proquest_miscellaneous_1020828355 pubmed_primary_22701274 crossref_citationtrail_10_1155_2012_410232 crossref_primary_10_1155_2012_410232 hindawi_primary_10_1155_2012_410232 emarefa_primary_998902 airiti_journals_P20160527003_201212_201703010014_201703010014_725_733 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-01-01 |
PublicationDateYYYYMMDD | 2012-01-01 |
PublicationDate_xml | – month: 01 year: 2012 text: 2012-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Cairo, Egypt |
PublicationPlace_xml | – name: Cairo, Egypt – name: United States |
PublicationTitle | Mediators of Inflammation |
PublicationTitleAlternate | Mediators Inflamm |
PublicationYear | 2012 |
Publisher | Hindawi Limiteds Hindawi Publishing Corporation Wiley |
Publisher_xml | – name: Hindawi Limiteds – name: Hindawi Publishing Corporation – name: Wiley |
References | (33) 2009; 179 (12) 2005; 17 (9) 2005; 6 (23) 2002; 1 (25) 2007; 67 (13) 2006; 354 (29) 1985; 16 (3) 2003; 58 (20) 2006; 290 (30) 1967; 95 (7) 2000; 18 (16) 2007; 62 (31) 2008; 178 (15) 2007; 13 (27) 2009; 33 (5) 2004; 1, article e8 (2) 2007; 176 (32) 2004; 125 (10) 2007; 450 (14) 2005; 140 (19) 2010; 109 (26) 2008; 177 (6) 1999; 160 (22) 1991; 58 (35) 2007; 71 (28) 2003; 26 (36) 2009; 54 (17) 2007; 62 (4) 2002; 165 (24) 2006; 11 (11) 2006; 12 (21) 2002; 165 (34) 2009; 6 (8) 2006; 117 (1) 2001; 163 (18) 2008; 20 (37) 2005; 175 24 25 26 27 (33) 2004; 125 (38) 2005; 175 10 32 11 12 34 13 35 14 36 15 37 16 17 19 2 3 4 5 8 9 20 16085674 - Am J Physiol Lung Cell Mol Physiol. 2006 Jan;290(1):L75-85 18033300 - Nature. 2007 Nov 22;450(7169):566-9 11316667 - Am J Respir Crit Care Med. 2001 Apr;163(5):1256-76 4087316 - J Toxicol Environ Health. 1985;16(3-4):523-34 19950196 - J Cell Biochem. 2010 Feb 15;109(3):532-41 19407062 - Eur Respir J. 2009 May;33(5):1239 16540617 - N Engl J Med. 2006 Mar 16;354(11):1166-76 14514931 - Thorax. 2003 Oct;58(10):832-4 15526056 - PLoS Med. 2004 Oct;1(1):e8 1745845 - Respiration. 1991;58(3-4):145-9 14720429 - Zhonghua Jie He He Hu Xi Za Zhi. 2003 Dec;26(12):750-5 16476048 - Immunology. 2006 Mar;117(3):289-300 19060231 - Am J Respir Crit Care Med. 2009 Feb 15;179(4):271-8 17137638 - Int J Pediatr Otorhinolaryngol. 2007 Feb;71(2):297-305 6023510 - Am Rev Respir Dis. 1967 May;95(5):765-73 19403056 - Cell Mol Immunol. 2009 Apr;6(2):81-6 10556164 - Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 2):S21-5 17450149 - Nat Med. 2007 May;13(5):567-9 11956054 - Am J Respir Crit Care Med. 2002 Apr 15;165(8):1113-8 15807863 - Clin Exp Immunol. 2005 May;140(2):360-7 16635082 - Respirology. 2006 May;11(3):249-61 18723437 - Am J Respir Crit Care Med. 2008 Dec 1;178(11):1139-47 12016104 - Am J Respir Crit Care Med. 2002 May 15;165(10):1404-9 16209918 - Curr Opin Immunol. 2005 Dec;17(6):638-42 17507545 - Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55 14720066 - Am J Respir Med. 2002;1(2):119-31 19251402 - J Dermatol Sci. 2009 Jun;54(3):185-91 19028624 - J Chemother. 2008 Oct;20(5):604-8 17311843 - Thorax. 2007 May;62(5):411-5 10837065 - Annu Rev Immunol. 2000;18:423-49 17557771 - Thorax. 2007 Nov;62(11):938-43 16462800 - Nat Med. 2006 Feb;12(2):178-80 17947611 - Am J Respir Crit Care Med. 2008 Jan 15;177(2):148-55 14872003 - Chest. 2004 Feb;125(2 Suppl):70S-78S 15785759 - Nat Immunol. 2005 Apr;6(4):338-44 16339544 - J Immunol. 2005 Dec 15;175(12):8069-76 17488142 - Drugs. 2007;67(7):965-74 |
References_xml | – volume: 176 start-page: 532 issue: 6 year: 2007 end-page: 555 ident: 2 article-title: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary – volume: 18 start-page: 423 year: 2000 end-page: 449 ident: 7 article-title: Regulatory T cells in autoimmmunity – volume: 20 start-page: 604 issue: 5 year: 2008 end-page: 608 ident: 18 article-title: Effect of long-term and low-dose administration of erythromycin on proliferation of T lymphocytes stimulated with mitogens – volume: 26 start-page: 750 issue: 12 year: 2003 end-page: 755 ident: 28 article-title: An experimental study on airway inflammation and remodeling in a rat model of chronic bronchitis and emphysema – volume: 62 start-page: 411 issue: 5 year: 2007 end-page: 415 ident: 16 article-title: Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee – volume: 177 start-page: 148 issue: 2 year: 2008 end-page: 155 ident: 26 article-title: Clarithromycin targets neutrophilic airway inflammation in refractory asthma – volume: 109 start-page: 532 issue: 3 year: 2010 end-page: 541 ident: 19 article-title: Anti-inflammatory function of withangulatin a by targeted inhibiting COX-2 expression via MAPK and NF- B pathways – volume: 6 start-page: 81 issue: 2 year: 2009 end-page: 86 ident: 34 article-title: Chronic obstructive pulmonary disease: evidence for an autoimmune component – volume: 54 start-page: 185 issue: 3 year: 2009 end-page: 191 ident: 36 article-title: Roxithromycin inhibits chemokine-induced chemotaxis of Th1 and Th2 cells but regulatory T cells – volume: 11 start-page: 249 issue: 3 year: 2006 end-page: 261 ident: 24 article-title: Diffuse panbronchiolitis in East Asia – volume: 58 start-page: 145 issue: 3-4 year: 1991 end-page: 149 ident: 22 article-title: Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis – volume: 33 issue: 5, article 1239 year: 2009 ident: 27 article-title: Macrolide therapy in asthma: limited treatment, long-term improvement – volume: 165 start-page: 1404 issue: 10 year: 2002 end-page: 1409 ident: 4 article-title: Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease – volume: 179 start-page: 271 issue: 4 year: 2009 end-page: 278 ident: 33 article-title: Clarithromycin prevents smoke-induced emphysema in mice – volume: 71 start-page: 297 issue: 2 year: 2007 end-page: 305 ident: 35 article-title: Effects of macrolides on antigen presentation and cytokine production by dendritic cells and T lymphocytes – volume: 6 start-page: 338 issue: 4 year: 2005 end-page: 344 ident: 9 article-title: Mechanisms of suppression by suppressor T cells – volume: 12 start-page: 178 issue: 2 year: 2006 end-page: 180 ident: 11 article-title: Natural regulatory T cells control the development of atherosclerosis in mice – volume: 67 start-page: 965 issue: 7 year: 2007 end-page: 974 ident: 25 article-title: Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis? – volume: 16 start-page: 523 issue: 3-4 year: 1985 end-page: 534 ident: 29 article-title: Passive and active exposure to cigarette smoke in a smoking experiment – volume: 125 start-page: 70S issue: 2 year: 2004 end-page: 78S ident: 32 article-title: Immunomodulatory activity and effectiveness of macrolides in chronic airway disease – volume: 290 start-page: L75 issue: 1 year: 2006 end-page: L85 ident: 20 article-title: Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells – volume: 95 start-page: 765 issue: 5 year: 1967 end-page: 773 ident: 30 article-title: The internal surface area of nonemphysematous lungs – volume: 140 start-page: 360 issue: 2 year: 2005 end-page: 367 ident: 14 article-title: CD4 CD25 T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis – volume: 117 start-page: 289 issue: 3 year: 2006 end-page: 300 ident: 8 article-title: Imbalance of regulatory T cells in human autoimmune diseases – volume: 17 start-page: 638 issue: 6 year: 2005 end-page: 642 ident: 12 article-title: How do CD4 CD25 regulatory T cells control autoimmunity? – volume: 450 start-page: 566 issue: 7169 year: 2007 end-page: 569 ident: 10 article-title: The inhibitory cytokine IL-35 contributes to regulatory T-cell function – volume: 175 start-page: 8069 issue: 12 year: 2005 end-page: 8076 ident: 37 article-title: Erythromycin differentially inhibits lipopolysaccharide- or poly(I:C)-induced but not peptidoglycan-induced activation of human monocyte-derived dendritic cells – volume: 58 start-page: 832 issue: 10 year: 2003 end-page: 834 ident: 3 article-title: Hypothesis: does COPD have an autoimmune component? – volume: 163 start-page: 1256 issue: 5 year: 2001 end-page: 1276 ident: 1 article-title: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary – volume: 165 start-page: 1113 issue: 8 year: 2002 end-page: 1118 ident: 21 article-title: Erythromycin inhibits rhinovirus infection in cultured human tracheal epithelial cells – volume: 62 start-page: 938 issue: 11 year: 2007 end-page: 943 ident: 17 article-title: Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial – volume: 354 start-page: 1116 issue: 11 year: 2006 end-page: 1176 ident: 13 article-title: Regulation of immune responses by T cells – volume: 1, article e8 year: 2004 ident: 5 article-title: An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema – volume: 13 start-page: 567 issue: 5 year: 2007 end-page: 569 ident: 15 article-title: Antielastin autoimmunity in tobacco smoking-induced emphysema – volume: 1 start-page: 119 issue: 2 year: 2002 end-page: 131 ident: 23 article-title: Diffuse panbronchiolitis: role of macrolides in therapy – volume: 178 start-page: 1139 issue: 11 year: 2008 end-page: 1147 ident: 31 article-title: Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations – volume: 160 start-page: S21 issue: 5 year: 1999 end-page: S25 ident: 6 article-title: Chronic obstructive pulmonary disease: inflammation of small airways and lung parenchyma – ident: 17 doi: 10.1136/thx.2006.071068 – ident: 34 doi: 10.1164/rccm.200806-905OC – ident: 14 doi: 10.1111/j.1365-2249.2005.02754.x – volume: 95 start-page: 765 issue: 5 year: 1967 ident: 30 publication-title: American Review of Respiratory Disease – volume: 125 start-page: 70S issue: 2 year: 2004 ident: 33 publication-title: Chest doi: 10.1378/chest.125.2_suppl.70S – volume: 18 start-page: 423 year: 2000 ident: 7 publication-title: Annual Review of Immunology doi: 10.1146/annurev.immunol.18.1.423 – ident: 15 doi: 10.1038/nm1583 – ident: 25 doi: 10.2165/00003495-200767070-00002 – volume: 1 start-page: 119 issue: 2 year: 2002 ident: 23 publication-title: American Journal of Respiratory Medicine doi: 10.1007/BF03256601 – ident: 27 doi: 10.1183/09031936.00000209 – volume: 20 start-page: 604 issue: 5 year: 2008 ident: 18 publication-title: Journal of Chemotherapy doi: 10.1179/joc.2008.20.5.604 – volume: 165 start-page: 1113 issue: 8 year: 2002 ident: 21 publication-title: American Journal of Respiratory and Critical Care Medicine doi: 10.1164/ajrccm.165.8.2103094 – ident: 2 doi: 10.1164/rccm.200703-456SO – volume: 26 start-page: 750 issue: 12 year: 2003 ident: 28 publication-title: Zhonghua Jie He He Hu Xi Za Zhi – ident: 13 doi: 10.1056/NEJMra055446 – ident: 5 doi: 10.1371/journal.pmed.0010008 – ident: 8 doi: 10.1111/j.1365-2567.2005.02317.x – volume: 160 start-page: S21 issue: 5 year: 1999 ident: 6 publication-title: American Journal of Respiratory and Critical Care Medicine – ident: 3 doi: 10.1136/thorax.58.10.832 – ident: 26 doi: 10.1164/rccm.200707-1134OC – ident: 9 doi: 10.1038/ni1180 – ident: 32 doi: 10.1164/rccm.200801-145OC – ident: 10 doi: 10.1038/nature06306 – ident: 11 doi: 10.1038/nm1343 – volume: 58 start-page: 145 issue: 3-4 year: 1991 ident: 22 publication-title: Respiration doi: 10.1159/000195915 – volume: 16 start-page: 523 issue: 3-4 year: 1985 ident: 29 publication-title: Journal of Toxicology and Environmental Health doi: 10.1080/15287398509530760 – ident: 35 doi: 10.1038/cmi.2009.11 – ident: 36 doi: 10.1016/j.ijporl.2006.10.016 – volume: 163 start-page: 1256 issue: 5 year: 2001 ident: 1 publication-title: American Journal of Respiratory and Critical Care Medicine doi: 10.1164/ajrccm.163.5.2101039 – ident: 19 doi: 10.1002/jcb.22430 – ident: 20 doi: 10.1152/ajplung.00093.2005 – ident: 16 doi: 10.1136/thx.2006.072348 – ident: 37 doi: 10.1016/j.jdermsci.2009.01.007 – ident: 24 doi: 10.1111/j.1440-1843.2006.00845.x – ident: 4 doi: 10.1164/rccm.2107139 – ident: 12 doi: 10.1016/j.coi.2005.09.002 – volume: 175 start-page: 8069 issue: 12 year: 2005 ident: 38 publication-title: The Journal of Immunology doi: 10.4049/jimmunol.175.12.8069 – reference: 16462800 - Nat Med. 2006 Feb;12(2):178-80 – reference: 14514931 - Thorax. 2003 Oct;58(10):832-4 – reference: 15807863 - Clin Exp Immunol. 2005 May;140(2):360-7 – reference: 17947611 - Am J Respir Crit Care Med. 2008 Jan 15;177(2):148-55 – reference: 10837065 - Annu Rev Immunol. 2000;18:423-49 – reference: 10556164 - Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 2):S21-5 – reference: 16635082 - Respirology. 2006 May;11(3):249-61 – reference: 17137638 - Int J Pediatr Otorhinolaryngol. 2007 Feb;71(2):297-305 – reference: 16476048 - Immunology. 2006 Mar;117(3):289-300 – reference: 14872003 - Chest. 2004 Feb;125(2 Suppl):70S-78S – reference: 19060231 - Am J Respir Crit Care Med. 2009 Feb 15;179(4):271-8 – reference: 19407062 - Eur Respir J. 2009 May;33(5):1239 – reference: 17311843 - Thorax. 2007 May;62(5):411-5 – reference: 16209918 - Curr Opin Immunol. 2005 Dec;17(6):638-42 – reference: 19028624 - J Chemother. 2008 Oct;20(5):604-8 – reference: 19251402 - J Dermatol Sci. 2009 Jun;54(3):185-91 – reference: 4087316 - J Toxicol Environ Health. 1985;16(3-4):523-34 – reference: 18723437 - Am J Respir Crit Care Med. 2008 Dec 1;178(11):1139-47 – reference: 19403056 - Cell Mol Immunol. 2009 Apr;6(2):81-6 – reference: 1745845 - Respiration. 1991;58(3-4):145-9 – reference: 16540617 - N Engl J Med. 2006 Mar 16;354(11):1166-76 – reference: 18033300 - Nature. 2007 Nov 22;450(7169):566-9 – reference: 6023510 - Am Rev Respir Dis. 1967 May;95(5):765-73 – reference: 15785759 - Nat Immunol. 2005 Apr;6(4):338-44 – reference: 11316667 - Am J Respir Crit Care Med. 2001 Apr;163(5):1256-76 – reference: 16339544 - J Immunol. 2005 Dec 15;175(12):8069-76 – reference: 17488142 - Drugs. 2007;67(7):965-74 – reference: 14720066 - Am J Respir Med. 2002;1(2):119-31 – reference: 17507545 - Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55 – reference: 14720429 - Zhonghua Jie He He Hu Xi Za Zhi. 2003 Dec;26(12):750-5 – reference: 15526056 - PLoS Med. 2004 Oct;1(1):e8 – reference: 17557771 - Thorax. 2007 Nov;62(11):938-43 – reference: 12016104 - Am J Respir Crit Care Med. 2002 May 15;165(10):1404-9 – reference: 17450149 - Nat Med. 2007 May;13(5):567-9 – reference: 19950196 - J Cell Biochem. 2010 Feb 15;109(3):532-41 – reference: 11956054 - Am J Respir Crit Care Med. 2002 Apr 15;165(8):1113-8 – reference: 16085674 - Am J Physiol Lung Cell Mol Physiol. 2006 Jan;290(1):L75-85 |
SSID | ssj0005448 |
Score | 2.1288097 |
Snippet | Heavy smoking can induce airway inflammation and emphysema. Macrolides can modulate inflammation and effector T-cell response in the lungs. However, there is... |
SourceID | doaj pubmedcentral proquest pubmed crossref hindawi emarefa airiti |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 725 |
SubjectTerms | Animals CD4-Positive T-Lymphocytes - metabolism Enzyme-Linked Immunosorbent Assay Erythromycin - therapeutic use Forkhead Transcription Factors - metabolism Interleukin-8 - metabolism Pneumonia - chemically induced Pneumonia - drug therapy Pneumonia - immunology Pneumonia - metabolism Rats Reverse Transcriptase Polymerase Chain Reaction Smoking - adverse effects Tumor Necrosis Factor-alpha - metabolism |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9swEBejsLGXsa9u3hca69OKaKwPy37cspRurGN0LfRNSLJEwlK7JCkl_33vLCfUo2wvewpyLsKn-0l3F0m_I2QvF0XlrLMM3MGIyVrXrHQiMqxtXJcir7XHu8PHP4qjM_ntXJ3fKvWFZ8ISPXAauAOpbXQqQJRipbQ22tzFMugCoDoSoa5x9QWft0mmNoc7ZFc3C-Jzziqh8v5mHjhPyPZzfiCRsYCD17Ez5A4aOKWOu7-7oGuhDQ7r_hTT4-vZXUHon2cpbzmnw8fkUR9V0k9JmyfkXmiekgfH_b75M9JMFmssiHCxhjadNFO09ZKOv8h9cD-XYp-epJr07WJNT9k4zOfwpDs9C2LwE0tP7Ipi4bQ5bSP9ddH-DgzLfvhQ0--wYNCvTQRwpYuQz8nZ4eR0fMT6SgvMKlGsmI4WkuqofBHKIKvCe899nZdWWytjIZB1LsKIY3ZTOmdzASYpi2IUpBe-imKX7DRtE14SOuIeMhRVlkIGqQKkU1UNYUzFo7PcjXhGJmnMTT9ZluYnR5o7hVvgwqB5co4fuBYhQ5QcNjRXRguRkY8bkxnf05ljVY256dIapbqeTDJ0Rva2wpeJxeNusc9o-60IUm93DwCQpgek-RcgM7LbI2fbD6S0FWr-oQfS39_h_QZkBmY6bt_YJrRXSxDmyDcIAWJGXiTQbTviMHg51zIjegDHgSrDb5rZtGMTFwKrNKpX_0P31-QhqpL-onpDdlaLq_AWgraVe9fNzxuy8TUx priority: 102 providerName: Directory of Open Access Journals – databaseName: Hindawi Publishing Open Access dbid: RHX link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELdgEogXND7GwgAZsScmi8QfcfIIpVNBDKGxSX2zHMdWK7pkajuh_vfcJV4hY0I8RU4ulp07--5i-_cj5DATeVnZyjJwBymTta5ZUYnAkNu4LkRWa4dnh0--5pNz-XmqpnGD7OrvJXzwdpCeZ_ydRIgBmGrvgn1hTj6Z_t7IITuOLIjFOSuFyuIpvBuvgoexc8QJGjigDqe_O4xroQzO6d4MU-Gf89sCzpv7Jv9wRMe75GGMIOn7XuWPyB3fPCb3T-Ia-RPSjJcbJD-42ECZjpsZ6nVFRx_lEbiaS3FET3v--Xa5oWds5BcLuNPtlAUxeMXSU7umSJK2oG2g3y_aH54hxYfzNf0CkwP91AQwpP7Q41Nyfjw-G01YZFVgVol8zXSwkEAH5XJfeFnmzjnu6qyw2loZcoEIcwEmAsxkiqqymaiUL_I89dIJVwaxR3aatvH7hKbcQTaiikJIL5WH1KmsIWQpeagsr1KekHH_zU0cGCvzjSOkncLlbmFQPRnHC847iAYlhwXNldFCJOTttcqMi9DlyKCxMF0Ko1RXk-kVnZDDrfBlj9hxu9gH1P1WBGG2uxtgeiaOWiO1DdB7CJGtlNYGm1Wh8DpPsfm-rhOyFy1nWw-kryX2_E00pH-34fW1kRkY1bhUYxvfXq1AmCO2IASDCXnWG922Ig4fL-NaJkQPzHHQleGTZj7rkMOFQEZG9fy_WndAHmCp_9_0guysl1f-JURg6-pVNwB_AWUmILY priority: 102 providerName: Hindawi Publishing |
Title | Erythromycin Enhances CD4^+Foxp3^+ Regulatory T-Cell Responses in a Rat Model of Smoke-Induced Lung Inflammation |
URI | https://www.airitilibrary.com/Article/Detail/P20160527003-201212-201703010014-201703010014-725-733 https://search.emarefa.net/detail/BIM-998902 https://dx.doi.org/10.1155/2012/410232 https://www.ncbi.nlm.nih.gov/pubmed/22701274 https://www.proquest.com/docview/1020828355 https://pubmed.ncbi.nlm.nih.gov/PMC3371355 https://doaj.org/article/47afb5e774a44aafa1bf8e7607003edd |
Volume | 2012 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELemIRAviK9BBlRG7IkpkPgzeUAIRqcCKkJolfoWOYlNK7pkSztB_3vunLSQqUK8tHJ6cW3f2XfnxL8fIUcxV2luchOCO4hCUeoyTHLuQuQ2LhMel7rAs8PjL2o0EZ-mcrpHNmSc3QAud6Z2yCc1aRavfl2u38KEf-MnvJSQv8fstUAMAliLb4BL0khlMBZ_YMOl8DRasCqoME5U3B3Uu3YzOCEzRyihno_yUP7-vK6BMvivmzPMln_Od8Wk11-t_MtXnd4ld7ogk75rreIe2bPVfXJr3D1Gf0CqYbNGfoTzNZSprWao-iU9-SCOwRtd8GPatBT1dbOmZyFu7sMV_zItiMEthoLhUM-iQ2tHl-f1DxtCe8FOSrqA9QOEHNhaey7yIZmcDs9ORmFHvBAaydUq1M5Aju1koWxiRaqKomBFGSdGGyOc4ghC52CtwGQnyXMT81zaRKnIioIXqeMHZL-qK_uY0IgVkLDIJOHCCmkhu0pLiGpS5nLD8ogFZNiOebZRffaVIeqdxCfiPEP1xAy_cGlCwCjRL2gmM815QF5uVJYVHbo5kmwsMp_lSOlrylpFB-RoK3zRgnrsFnuPut-KIBK3v1A337NuYmdCGwe9hyjaCGGMM3HuEqtVhM23ZRmQg85ytvVAhptiz190hvTvNjzfGFkGEx8VbipbXy1BmCH8IMSLAXnUGt22IgaDFzMtAqJ75tjrSv-Xaj7z4OKcI2mjPPyP_31CbmNL2w2pp2R_1VzZZxCirfIBJCcfPw_8BsfAT0X4_Daa_gZMXTNA |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Erythromycin+enhances+CD4%2BFoxp3%2B+regulatory+T-cell+responses+in+a+rat+model+of+smoke-induced+lung+inflammation&rft.jtitle=Mediators+of+inflammation&rft.au=Bai%2C+Jing&rft.au=Qiu%2C+Shi-Lin&rft.au=Zhong%2C+Xiao-Ning&rft.au=Huang%2C+Qiu-Ping&rft.date=2012-01-01&rft.issn=1466-1861&rft.eissn=1466-1861&rft.volume=2012&rft.spage=410232&rft_id=info:doi/10.1155%2F2012%2F410232&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0962-9351&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0962-9351&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0962-9351&client=summon |